logo
Max Healthcare Institute to invest Rs 6,000 cr to add 3,700 beds by 2028

Max Healthcare Institute to invest Rs 6,000 cr to add 3,700 beds by 2028

Max Healthcare Institute Ltd will invest Rs 6,000 crore by 2028 to add 3,700 beds across key locations in India, its Chairman and Managing Director Abhay Soi said on Tuesday.
Max Healthcare, which operates 22 healthcare facilities with around 5,000 beds currently could have around 30 hospitals by 2028, Soi told PTI.
Speaking at the sidelines of the inauguration of Max Super Speciality Hospital, Dwarka, a 300-bed greenfield facility, he said the company will be "reinvesting whatever we generate over the next 10 years to create healthcare assets".
"This year alone, we are opening four (hospitals). This (Dwarka) was the first of the four," Soi said.
Max Healthcare plans to inaugurate three other hospitals in Mohali, Mumbai, and Saket, New Delhi later this year.
The inauguration of the Dwarka hospital is a strategic step in Max Healthcare's broader expansion plan to add 3,700 beds across key locations in India by 2028, the company said.
"Some existing hospitals will be expanded and some new hospitals will come up," he said, adding by 2028 Max Healthcare expects to have around 30 hospitals in total.
When asked about investments for the overall expansion, Soi said, "It will be about Rs 6,000 crore...we're internally funding it. We will be reinvesting all our profits into only creating new hospital beds." On whether the company will consider acquisitions in the future, Soi, "We are opportunistic about it, as and when we get the opportunity, we will buy." The budget for acquisition will be over and above the investment earmarked for organic expansion, he added.
The new facility at Dwarka houses over 120 critical care beds, 10 modular operation theatres, and advanced Cath Labs.
It also offers advanced tertiary and quaternary care across key specialties, including cardiac sciences, oncology, renal sciences, neurosciences, robotic surgery, pediatrics, and organ transplants. Soi said Delhi-NCR is a critical hub for advanced medical care, and Dwarka, given its strong connectivity to multiple parts of Delhi, is perfectly positioned to meet the region's growing healthcare needs.
"As a greenfield venture, this facility reflects our intent to expand meaningfully by building high-quality infrastructure in locations that improve accessibility," he noted.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tata Motors Shares Fall 5% After JLR Sees Lower Margins For FY26; Key Points
Tata Motors Shares Fall 5% After JLR Sees Lower Margins For FY26; Key Points

News18

time33 minutes ago

  • News18

Tata Motors Shares Fall 5% After JLR Sees Lower Margins For FY26; Key Points

Last Updated: Shares of Tata Motors Ltd., the leading manufacturer of passenger and commercial vehicles, declined by as much as 5% Shares of Tata Motors Ltd., the leading manufacturer of passenger and commercial vehicles, declined by as much as 5% on Monday, June 16, after its subsidiary, Jaguar Land Rover (JLR), issued a subdued outlook for the current financial year, falling short of last year's performance expectations. Jaguar Land Rover (JLR), the UK subsidiary of Tata Motors, has provided a muted outlook for FY26, forecasting an EBIT margin between 5% and 7%, a decline from the 8.5% margin it achieved in the previous fiscal year. In FY25, JLR generated a robust free cash flow of £1.5 billion. However, the company now expects that figure to fall 'close to zero" in the current financial year. Despite this short-term weakness, JLR management is optimistic about the medium term, aiming to improve free cash flow from FY27 onward and targeting a return to a 10% EBIT margin—though no specific timeline has been disclosed. JLR remains a critical driver of Tata Motors' financial performance, contributing 71% to the company's revenue and 80% of its overall profit in FY25. The average revenue per unit stood firm at over £70,000 on a year-on-year basis. On trade policy, JLR stated it continues to engage with the Trump Administration. The UK-US trade agreement is expected to reduce tariffs from 27.5%, though tariffs on imports from Slovakia remain unchanged. Following the subdued guidance, Tata Motors' shares dropped 4.6% on Monday to Rs 679.65, making it the biggest loser on the Nifty 50 and among the top decliners on the Nifty 500. First Published: June 16, 2025, 10:01 IST

GST dept busts Rs 14 crore refund fraud, Rs 1.16 crore retrieved from Delhi firm
GST dept busts Rs 14 crore refund fraud, Rs 1.16 crore retrieved from Delhi firm

New Indian Express

time34 minutes ago

  • New Indian Express

GST dept busts Rs 14 crore refund fraud, Rs 1.16 crore retrieved from Delhi firm

NEW DELHI: The Department of Trade and Taxes, Government of Delhi, has uncovered a major case of Goods and Services Tax (GST) refund fraud amounting to nearly Rs 14 crore. The investigation revealed a network of individuals who created and operated four fictitious firms solely to illegitimately claim GST refunds under the guise of genuine business activities. This case marks a first-of-its-kind operation by the Department, where cutting-edge big data analytics and detailed chain analysis—including scrutiny of banking transactions—were employed to trace the flow of funds across multiple entities located in Delhi, other states, and international jurisdictions such as Hong Kong and Singapore. The Department's data-driven investigation identified multiple entities using the same PAN, mobile numbers, and email addresses as those used by the fraudulent firms. As an immediate enforcement measure, the registration of the Delhi-based entities has been suspended.

Stocks to watch on June 16: Adani Enterprises, Sun Pharma, NTPC, Bajaj Finance
Stocks to watch on June 16: Adani Enterprises, Sun Pharma, NTPC, Bajaj Finance

India Today

time34 minutes ago

  • India Today

Stocks to watch on June 16: Adani Enterprises, Sun Pharma, NTPC, Bajaj Finance

Stock markets are expected to start the new week on a cautious note on June 16, as global investors closely track ongoing geopolitical tensions in the Middle the previous week, the stock market fell by over 1% due to nervousness around rising crude oil prices and global trading resumes on Monday, shares of several companies will be in focus due to fresh developments. These include Adani Enterprises, Sun Pharma, NTPC, Bajaj Finance, Vedanta, and ENTERPRISESAdani Enterprises will be one of the top stocks to watch after the company clarified reports regarding damage to its Haifa Port in Israel. The clarification came after news reports claimed the port was hit by an Iranian Sunday, Jugeshinder Robbie Singh, the Chief Financial Officer of the Adani Group, said these reports are false. He stated that the Haifa Port has not suffered any damage and that the port is operating as statement comes at a time when investors are reacting sharply to global events, especially those linked to the Middle East PHARMASun Pharmaceutical confirmed that the US Food and Drug Administration (FDA) completed an inspection of its Halol plant. The inspection ended with eight observations issued in a Form 483 inspections are important for pharmaceutical companies as they decide whether the company can continue to supply medicines to the US, one of its biggest markets. Investors will be watching to see how the company responds to these FINANCEBajaj Finance shares will be in the spotlight as they will trade ex-bonus and ex-stock split starting June 17. The company had announced a bonus issue in the ratio of 4:1, meaning shareholders will receive four additional shares for each share with this, the face value of each share will be split from Rs 2 to Rs 1, making the shares more affordable for retail investors. These changes were part of the company's announcements during its fourth-quarter earnings the state-run power producer, announced that it has started commercial operations at Unit-3 of the North Karanpura Super Thermal Power Project. This unit has a capacity of 660 start of commercial operations means the company can now earn revenue from power generated by this unit, which could help boost its financial performance in the coming announced the completion of its acquisition of 100% stake in Sresta Natural Bioproducts (SNBPL) for Rs 400 crore. As a result, SNBPL and its overseas companies in the US and UAE have now become wholly owned subsidiaries of has said it will hold a board meeting on June 18 to consider an interim dividend for the current financial year, FY26. The company has fixed June 24 as the record date to determine which shareholders are eligible to receive the are payouts made to shareholders, and news of such proposals can influence stock prices ahead of the board TECHNOLOGIESGaming and media firm Nazara Technologies will also be under focus after well-known investor Rekha Jhunjhunwala sold over 27 lakh shares in the company on June move reduced her holding in the firm. Large stake sales by key investors usually draw attention in the stock market, and share prices may react INTERNATIONALBiotech firm Syngene International has received an Establishment Inspection Report (EIR) from the US FDA for its GMP manufacturing units located in Biocon Park. This report suggests that the FDA has completed its inspection and has no immediate regulatory is seen as a positive sign for the company and may lead to investor interest in the stock. advertisement

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store